China Food and Drug Administration has approved the sale of a new drug for the treatment of HIV-1 infection.
Makers of the drug, Frontier Biotech, a pharmaceutical company based in China said Aikening, or Albuvirtide injection, said it can be used with other antiretroviral drugs to treat infected patients who suffer from viral replication.
It said data from clinical trials showed that Aikening was effective against major strains of HIV, including resistant viruses, with long acting efficacy.
Advertisements
